News story

Successful reclassification of Nasonex Allergy Control Nasal Spray

MHRA reclassifies Nasonex Allergy Control

MHRA logo

Nasonex Allergy Control 0.05% Nasal Spray will soon be available to buy over the counter in pharmacies following a public consultation by the Medicines and Healthcare products Regulatory Agency (MHRA). This nasal spray is used to treat the symptoms of allergic rhinitis such as sneezing and a runny, itchy or blocked up nose which may be caused by hay fever.

Nasonex Allergy Control is a nasal spray containing an active ingredient called mometasone furoate. This is the first product containing mometasone furoate to be available without prescription. MHRA are committed to involving people in their healthcare, and to widen access to medicines for the benefit of public health when it is safe to do.

Published 10 July 2017